New patent for Glaxo Grp drug INCRUSE ELLIPTA

Annual Drug Patent Expirations for INCRUSE+ELLIPTA Incruse Ellipta is a drug marketed by Glaxo Grp England and is included in one NDA. It is available from one supplier. There are…

The post New patent for Glaxo Grp drug INCRUSE ELLIPTA appeared first on DrugPatentWatch - Make Better Decisions.


Comments are closed.

Biotechblog